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Theenhancedanalyticalperformancesofimmunoassaysthatemployedsite-directlyimmobilizedantibodiesasthecapturebinders
have been functionally characterized in terms of antigen-antibody complex formation on solid surfaces. Three antibody species
speciﬁctocardiactroponinI,immunoglobulinG(IgG),Fab,andF(ab
 )2 weresite-directlybiotinylatedwithinthehingeregionand
then immobilized via a streptavidin-biotin linkage. The new binders were more eﬃcient capture antibodies in the immunoassays
comparedtorandomlyboundIgG,particularly,inthelowantibodydensityrange.Theobservedimprovementscouldhaveresulted
from controlled molecular orientation and also from ﬂexibility, oﬀering conditions suitable for binding complex formations.
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1.Introduction
Immuno-analyticalsystemshavetypicallybeendevelopedby
capturing and immobilizing the antibody on solid surfaces
since the immobilization provides an easy separation of
the binding complexes with the antibody from unreacted
reagents [1]. The solid-phase capture antibody, however, is
very diﬃcult to control at the level of the molecular state
or orientation on the surfaces, which is a major factor that
determines the degree of the complex formation [2]. Indeed,
most immobilization methods (e.g., physical adsorption,
covalent attachment, and binding via biotin-streptavidin
linkage) [2, 3] have not yet been very successful in arranging
or orientating the antibody molecules [4] in a manner
that substantially improves the random nature of antibody
immobilization inherent in the current methods. Random
immobilization results in a low rate (e.g., 5 to 10%) of the
active antibody density, that is, those that can participate in
the binding reaction, which decreases even further when the
substance to be analyzed is large in molecular size [2].
The rate of active antibody density would signiﬁcantly
increase provided the molecules are deposited by mediating
the Fc region on the solid matrix, such that the antibody
binding sites may face to the bulk solution where the analyte
is present. As a typical example, protein A or G binds
speciﬁcally to the Fc region of immunoglobulin [5] and,
thus, the capture antibody can be immobilized via this
binding protein in the “bottom-on” conﬁguration. It has
been demonstrated that such a controlled molecular orien-
tation of the antibody signiﬁcantly improves the binding rate
compared to random immobilization of the antibody by up
to about 10 times for the same antigen [3]. The functional
binding aﬃnity measured for the oriented antibody could
also increase because the molecules are properly posed to
orient the binding sites at a position distal from the surfaces.
Such improved characteristics would consequently enhance
the analytical performances of solid-phase immunoassays
[3, 6]. However, it is worth noting that the use of antibodies
immobilized via the binding proteins is limited to only
competitive-type assays in which only a single antibody is
used.
Todevelopanimmobilizationschemethatcanbeusedin
a wide range of applications, we have explored site-directed
biotinylationofantibodiestobindthemoleculesviaabiotin-
streptavidin linkage on the solid surfaces [7]. Since the hinge
region of immunoglobulin G (IgG) could be a potential site2 Journal of Biomedicine and Biotechnology
for coupling to the matrix, a novel method was devised
to selectively attach a biotin derivative to the functional
groups present within this region. Although this product,
if used as the capture antibody, led to an enhancement in
the performance of the sandwich-type immunoassay, the Fc
region in the molecule was likely interfere with immobilizing
the antibody in an erect position, which is desirable for
binding. To address this, we next synthesized a product
biotinylated at the same region but using an antibody
fragment, F(ab
 )2,i np l a c eo fI g G[ 3]. The use of this
capture antibody further enhanced the performances of the
immunoassay, indicating that the molecules could not only
be positioned on the streptavidin layer in an arrangement
that eﬃciently exposed the binding sites to the bulk solution,
but also with a high ﬂexibility for access to the antigen. Such
improvements would be crucial to the analytical systems
for, particularly, cardiac troponin I (cTnI), as a speciﬁc
marker of acute myocardial infarction (AMI), requiring a
high detection capability.
In this study, we analyzed the complex formation with
the immobilized antibodies to cTnI prepared in diﬀerent
schemes using variable biotinylation methods and antibody
types. In the previous report, the site-directly biotinylated
antibodies were shown to be superior to the conventional
random preparation if they were used as the capture anti-
bodies in sandwich immunoassays [3]. As to the molecular
types, since the fragmented antibody without the Fc had
an enhancement eﬀect, the smaller fragment, Fab, was also
employed in this study to examine a new factor, that is,
the number of binding units per molecule. The respective
complex formation with such diﬀerent preparations have
been analyzed with respect to two major parameters deter-
mining the reaction; the surface density of active binding
sites and binding aﬃnity. Based on these analyses, we have
attempted to construct binding models that represent the
reactions of each antibody with the antigen on the solid
surfaces.Themodelscouldconsequentlybeusedtoelucidate
theeﬀectsofthefollowingfactorsonthecomplexformation:
biotinylation method, the presence of Fc, and the number of
binding units per molecule.
2.MaterialsandMethods
2.1. Materials. The stock of cTnI-T-C complex (from
human cardiac muscle tissue) and mouse monoclonal
antibody speciﬁc to cTnI (Clone 19C7) were supplied by
HyTest (Turku, Finland). Goat anti-mouse IgG antibody,
two types of goat anti-mouse IgG antibodies (speciﬁc
to whole IgG and Fc of mouse IgG, resp.) conjugated
with horseradish peroxidase (HRP), succinimidyl 4-[N-
maleimidomethyl]cyclohexane-1-carboxylate (SMCC), 1-
biotin-amido-4-(4 -[maleimidoethylcyclohexane]-carbox-
amido)butane (biotin-BMCC), succinimidyl-6-[biotin-am-
ido]-6-hexanamidohexanoate (NHS-LC-LC-biotin), and
ImmunoPure IgG1 Fab and F(ab
 )2 preparation kit were
purchased from Pierce (Rockford, IL). Mercaptoethanol
(ME), dithiothreitol (DTT), sephadex G-15 gel, 3,3 ,5,5 -
tetramethylbenzidine (TMB), casein (sodium salt type,
extracted from milk), glutaraldehyde (GA), protein marker
(low range), and polyoxyethylene sorbitan monolaurate
(Tween 20) were obtained from Sigma (St. Louis, MO).
Streptavidin and HRP were obtained from Calbiochem (San
Diego, CA). Ficin (from a ﬁg tree) protease was purchased
from Wako (Osaka, Japan). A protein G aﬃnity column was
supplied by Bio-rad (Hercules, CA). Other reagents used in
this study were analytical grade.
2.2. Substrate Solution for HRP. The substrate solution for
the microtiter-plate-based immunoassays contained 10mL
of 50mM sodium acetate (pH 5.1), 100µLo f1 %T M B ,a n d
10µLo f3 %h y d r o g e np e r o x i d e .
2.3. Preparation of Antibody Fragments
2.3.1. Production of Fab. A monoclonal antibody speciﬁc
to cTnI (BD clone 12) was produced by following a
standard protocol as described elsewhere [8]. The antibody
was fragmented using the ImmunoPure IgG1 Fab and
F(ab
 )2 Preparation Kit according to the manufacturer’s
instructions. Brieﬂy, the Ficin column (gel volume: 2mL)
was equilibrated with activation buﬀer containing 10mM
cysteine to eventually yield Fab as the product. The antibody
solution, diluted to 1mg/mL in phosphate buﬀered saline
(PBS), was added to the equilibrated Ficin column, and
incubated at 37
◦Cf o r5 hours. The digested antibody solu-
tion eluted from the column was immediately transferred to
the protein A column (gel volume: 2.5mL). After collection
of the unbound fractions, the bound antibody compo-
nents were collected with the elution buﬀer supplied in
the kit.
Each fraction obtained from the protein A column was
then analyzed by means of a solid-phase immunoassay with
an immobilized anti-mouse IgG antibody. The goat anti-
mouse IgG antibody (1µg/mL, 100µL) dissolved in PBS was
added to microwells and incubated within a container main-
tained at 100% relative humidity and 37
◦Cf o r1h o u r .T h e s e
incubation conditions were also applied to all subsequent
reaction steps. After washing the microwells three times
with deionized water, the residual surfaces were treated with
100mM Tris buﬀer, pH 7.6, containing 0.5% casein (Casein-
Tris; 200µL). After washing, each eluted fraction from the
protein A column were diluted 100 times with Casein-
Tris containing 0.1% Tween (Casein-Tris-TW) and added
(100µL) to duplicate wells. After washing, two types of anti-
mouse IgG antibodies (speciﬁc to whole IgG and Fc region
of mouse antibody, resp.), which were labeled with HRP,
were diluted 5000times with Casein-Tris-TW and subse-
quently added (100µL) to each sample. After washing, the
substrate solution for HRP (200µL) containing soluble TMB
was dispensed into each well and reacted at room temper-
ature for 15minutes. Sulfuric acid (2M, 50µL) was added,
and the absorbance was then measured at 450nm with
a microtiter plate reader (VERSAmax, Molecular Device,
Chicago, IL).
The eluted fractions were also characterized by sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) analysis (12% gel) under non-reducing conditions, as
described elsewhere [3].Journal of Biomedicine and Biotechnology 3
2.3.2. Production of F(ab
 )2. The same monoclonal anti-
body described in the production of Fab section was also
fragmented by Ficin protease dissolved in digestion buﬀer
(50mM Tris-HCl containing 2mM EDTA, pH 7.0). The
antibody (1mg) was mixed with the dissolved Ficin solution
(molar ratio of Ficin to antibody was 1 to 30) containing
1mM cysteine as an activator and the mixture was then
incubated at 37
◦C for 2 hours. After the enzymatic digestion,
the mixed solution was immediately transferred to the
protein G column (gel volume: 1mL), which had been pre-
equilibrated with 10mM PBS (pH 7.4). After collecting
the unbound fractions, the bound components were eluted
with 0.2M glycine buﬀer (pH 3.0). Each fraction from the
columnwasthenanalyzedbyoftheBradfordassayat595nm
[9].
To characterize the unbound and bound fractions, SDS-
PAGE and solid-phase immunoassay were employed, respec-
tively. The conditions used for the SDS-PAGE analysis (12%
gel) are described elsewhere [3]. In the immunoassay, the
goat anti-mouse IgG antibody (1µg/mL, 100µL) dissolved
in PBS was added to microwells and incubated within a
container maintained at 100% relative humidity and 37
◦C
for 1 hour. In this immunoassay, the incubation and washing
procedure of each reaction step were the same as the
conditions described in the production of Fab section. After
blockingtheresidualsurfacewithCasein-Tris,eachunbound
fraction, bound fraction and F(ab
 )2 fragment, pre-made
with a commercial kit as a control, was serially diluted (0
to 1000ng/mL) with Casein-Tris-TW and then added to
microwells. Following the reaction, anti-mouse IgG labeled
with HRP was added and signal generation was performed
by the same procedures described above.
2.4. Synthesis of Labeled Antibodies
2.4.1. Labeling Antibody with Biotin. The antibody molecule
can be biotinylated with a few commercially available cross-
linkers, which are reactive to some chemical functions that
exist on the outer surface of the antibody. We prepared
three types of antibody species (i.e., IgG, F(ab
 )2 and
Fab) and then produced the biotinylated antibodies using
not only an amine-reactive biotin (NHS-LC-LC-Biotin)
linker for random biotinylation of IgG type but also a
sulfhydryl-reactive biotin (biotin-BMCC) linker for site-
directed biotinylation of IgG, F(ab
 )2 and Fab types in this
study. For random biotinylation of IgG and site-directed
biotinylation of IgG and F(ab
 )2, the components were
prepared according to protocols we previously published
[3]. In addition, unlike the two antibodies from the site-
directed biotinylation method, that is, IgG and F(ab
 )2,
synthesis of site-directed biotinylation of Fab was performed
by a simple biotinylation process (ﬁve-fold molar excess of
biotin-BMCC) without inducing the competitive reaction
among maleimide derivatives [3] because Fab fragment
molecule contains just one disulﬁde bond that can be
reduced by reducing agents at the interchain between CH1
and CL domain. After site-directed biotinylation of Fab,
excess biotin-BMCC reagent was removed on a Sephadex
G-15 gel column (gel volume: 10mL). The biotinylated Fab
was then concentrated and stored at 4◦C until use.
2.4.2. Labeling Antibody with HRP. The monoclonal anti-
body, clone 19C7, was coupled to the enzyme, that is, HRP,
via a cross-linking protocol that was similar to a protocol
previously described elsewhere [10]. Brieﬂy, the antibody
was ﬁrst reduced using 10mM DTT at 37
◦Cf o r1h o u r ,
and the excess reagent was removed on Sephadex G-15
gel column (10mL volume). HRP was also activated with
SMCC in a 50molar excess, and the excess reagents were also
separated on the Sephadex G-15 gel column. The reduced
antibody was then combined with the activated HRP in a 5
molar excess and the conjugation was carried out overnight
at 4◦C. The conjugates synthesized were stored as aliquots
after snap freezing.
2.5. Performance Characterization of Immobilized Antibodies
2.5.1. Analytical Procedure. To analyze the performance of
the four diﬀerent biotinylated antibodies, that is, random
IgG,site-directedIgG,site-directedF(ab
 )2,andsite-directed
Fab, as capture agents, antibody immobilization on the inner
surfaces of microwells were performed by a streptavidin-
biotin linkage [11, 12]. A streptavidin solution (10µg/mL,
100µL) dissolved in PBS was added to the microwells
pre-treated with 0.5% glutaraldehyde and reacted within
a humidiﬁed container at 37
◦C for 1 hour. These incu-
bation conditions were used in all subsequent steps, and
the wells were washed with deionized water three times
after completing each step. After treating the well surfaces
with Casein-Tris, the four types of biotinylated antibodies
dissolved in Casein-Tris-TW were serially diluted (0.5, 5, 25,
and 75pmol/mL) and added to each microwell. Antigen-
antibodycomplexeswerethenformedbysequentiallyadding
variable analyte concentrations of cTnI-T-C (0, 0.01, 0.1, 1,
10, 100, 1000, and 2000ng/mL), and a constant amount of
mouse anti-cTnI antibody-HRP conjugates (1µg/mL). The
rest procedure for signal generation and measurement were
performed by the same procedures described above.
2.5.2. Data Manipulation. To investigate the antigen binding
patterns of the four types of biotinylated antibody partici-
pantsimmobilizedonstreptavidinlayer,weanalyzedthedata
obtained from the two-site immunoassay as described above.
The colorimetric signal data obtained from the each analyte
concentration were quantiﬁed as molar concentration using
a linearized HRP standard curve [2]. The numerical values
were then transformed into the analytical parameters for
Scatchard plot analysis [13]. The surface density of the
reactive binding site and the equilibrium binding constant
were determined from the x-intercept and slope of the
regression curve.
3. Results and Discussion
To improve detection ability of cTnI, immunoassay systems
employing diﬀerent capture antibodies were investigated in
this study by immobilizing them, via a biotin-streptavidin4 Journal of Biomedicine and Biotechnology
linkage, in various conﬁgurations [3]. It has been reported
that the adoption of the site-directly biotinylated antibody
was superior in its analytical performance over the use of
the randomly prepared biotinylated antibody. Furthermore,
the presence of the Fc region in the site-directly biotinylated
antibody molecule may result in a steric eﬀect that was sig-
niﬁcantly alleviated provided an antibody fragment, F(ab
 )2,
was employed.
The aim of this study was to continue this work by
characterizing not only the surface density of immobilized
captured antibodies that were actively participating in the
reaction but also the binding aﬃnity, which primarily
determines analytical performance. It is worth noting that
the Fab fragment, which was used as the capture antibody
and could determine the minimal size of the binder, was
newly synthesized to more fully determine the controlling
factors.
3.1. Preparation of Antibody Fragments
3.1.1. Production of Fab. The smaller antibody fragment
was produced by enzymatically digesting the IgG1 mouse
antibody using a protease, Ficin, immobilized on a gel
column. To derive the reaction for mainly synthesizing
Fab, the antibody was incubated with 10mM cysteine,
which acted as an activator, within the column for an
extended time period (e.g., 5 hours) [14]. After collecting
the reaction mixture from the Ficin column, the product
was sequentially puriﬁed by aﬃnity chromatography on a
protein A column. The unbound portion was retrieved as
fractions and the bound portion was eluted by shifting the
medium to a low pH buﬀer. Each fraction was analyzed
for total antibody with a sandwich-type immunoassay using
a secondary antibody, as the capture binder, raised against
mouse whole IgG and the same antibody but chemically
conjugated to an enzyme, HRP, as the detection molecule. To
monitor Fab, the same immunoassay system was employed
except with the use of a detection antibody speciﬁc only
to the Fc region. The immunoassay results, as shown in
the chromatogram in Figure 1(a), revealed that the major
component in the unbound fractions in the ﬁrst peak was
Fabandthecomponentsintheboundfractionsinthesecond
peak contained Fc, including the non-digested IgG.
To verify that the major component in the unbound
fraction was Fab, the fractions were pooled and analyzed
by means of SDS-PAGE under non-reducing conditions
(Figure 1(b)). This analysis showed that the major protein
band had a molecular weight between 66 and 45kDa.
Impurities were also present although they were relatively
minor. Since the molecular size of Fab is approximately
50kDa, we can conclude that this major protein band is Fab
cleaved from IgG by Ficin. It should be noted that the yield
of Fab fragmentation by enzymes was approximately 50%
provided the areas under each antibody fragment peak were
compared with each other (refer to the curve marked with
open square in Figure 1(a)).
3.1.2. Production of F(ab
 )2 in Large Scale. Unlike the
above enzymatic digestion in the solid phase, F(ab
 )2 was
synthesized by carrying out the same cleavage reaction in the
solutionphasecontaining1mMcysteineasanactivator.This
method provided an improved yield of the reaction when
compared to the previous method although the enzyme
could not be reused. The antibody fragments were then
puriﬁed by aﬃnity chromatography on a protein G column,
which was essential for separating F(ab
 )2 in a high purity
from the reaction mixture containing the enzyme. After
eluting the unbound fractions, the bound material was
dissociated from the column by switching the medium to
al o wp Hb u ﬀer. To obtain the chromatogram the protein
concentration in each elution fraction was analyzed by the
Bradford assay (Figure 2(a)).
After pooling the fractions in each peak, the components
were analyzed by SDS-PAGE under non-reducing conditions
(the inset, Figure 2(a)). This analysis showed that the
unbound fractions included mainly the smaller fragment,
Fc, which had a molecular weight of about 50kDa, and the
bound fraction contained the larger fraction, F(ab
 )2,w h i c h
had a molecular weight of about 100kDa. These results
indicate that this method resulted in a complete isolation
of the product. The gel data, however, was in conﬂict with
the preconception that protein G speciﬁcally binds to the
Fc region of the antibody molecule, which would have
resulted in the opposite order of the eluted components.
To settle this contradiction, each fragment was reacted
with the antigen, cTnI, immobilized on the solid matrix,
and the complex was traced using a secondary antibody,
raised against mouse IgG, conjugated to an enzyme, HRP
(Figure 2(b)). The fragment that came from the bound
fractions showed a binding pattern to the antigen similarly
to that obtained with the F(ab
 )2 control. These results were
supported by a previous study [15]w h e r eF ( a b
 )2 produced
by the enzymatic digestion of the same subtype antibody
using Ficin was found to strongly bind to protein G whereas
the cleaved Fc poorly reacted with the binding protein under
physiological conditions.
Theliquidphasecleavagereactionhadseveraladvantages
relative to the solid phase cleavage employed in the earlier
investigation [3]. First, as shown in the SDS-PAGE data, only
the two Fc and F(ab
 )2 components were contained in the
unbound and bound peaks, respectively. This indicated that
the yield of fragmentation under the conditions used was
close to 100%, which was a signiﬁcant improvement over
the solid phase reaction (about 20 to 30%). Secondly, the
antibody cleavage was completed via enzymatic digestion
within 2 hours, which was about one-tenth the reaction time
required for the previous protocol (approximately 20 hours).
Finally, the reproducibility of the cleavage reaction was
remarkable as shown in the quadruplicate chromatograms
of Figure 2(a). All of these did not result from only the
enzymatic cleavage in the liquid phase, but also from the use
of Ficin without limitation in the quantity.
3.2. Comparison of Analytical Performances. Using the
biotinylated preparations as the capture antibody, immuno-
analytical systems were constructed to obtain the respective
dose-response curve for evaluating the analytical perfor-
mance of the antibody, in particular, the detection capabilityJournal of Biomedicine and Biotechnology 5
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Figure 1: Aﬃnity chromatography for the isolation of Fab from the antibody fragment mixture digested by Ficin protease and its
identiﬁcation. After loading the cleaved products on a protein A column, the unbound fractions were collected and the bound were eluted
by shifting the medium pH. Each fraction was analyzed for total antibody and for that with Fc, which showed that the unbound included
Fab and the bound consisted of fragments containing Fc (a). Furthermore, SDS-PAGE under non-reducing conditions conﬁrmed that Fab
was indeed the main component in the unbound portion. (b).
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Figure 2: Aﬃnity puriﬁcation of the digested fragments of IgG type antibody on a protein G column and their characterization. Elution
fractions from the column were analyzed for total protein by means of a Bradford assay (a). The fractions in each peak were pooled, which
were then identiﬁed by molecular size via SDS-PAGE under non-reducing conditions (inset, (a). The reactivities of each pooled fraction
were subsequently conﬁrmed by solid-phase immunoassays with cTnI as the antigen immobilized on the solid matrix (b)
(also expressed as sensitivity). The antibodies used in this
study were highly speciﬁc in measuring analyte, that is, cTnI
as a speciﬁc AMI marker, present in serum as a medium for
clinical tests [16, 17]. Each antibody were immobilized on
the inner surfaces of microwells in low and high densities
to establish the binding models, and sandwich-type enzyme
immunoassays were carried out to plot the signal against the
cTnI concentration (Figure 3).
From such prepared dose-response curves, the detection
limits for each antibody preparation were determined as
described previously [3]. With the antibodies immobilized
at a low density (Figure 3(a)), the conventional, randomly
biotinylated whole antibody showed the poorest sensi-
tivity (detection limit = 1.826ng/mL). When the site-
directly biotinylated whole antibody was employed, the
detection capability increased 6.1 times (detection limit =
0.297ng/mL). Adoption of the antibody fragments, F(ab
 )2
and Fab, further enhanced the sensitivity (0.205ng/mL for
the both). When the capture antibodies were immobilized
at a high density (Figure 3(b)), the assay sensitivity with6 Journal of Biomedicine and Biotechnology
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Figure 3: Dose-response curves for binding between each type of biotinylated antibody and cTnI at low (0.5pmol/mL addition) and high
(2.5pmol/mL) surface densities of the respective antibody. The antibodies were immobilized via biotin-streptavidin linkage and used as the
capture for carrying out sandwich enzyme immunoassays for cTnI. The signals produced from the assays were plotted against the analyte
concentration. The mean of triplicate determinations for each measurement and the corresponding standard deviations were indicated.
the random preparation remarkably increased by 6.6 times
(detection limit = 0.275ng/mL) compared to immobiliza-
tion at a low density. The site-directed products also showed
somewhat improvements (detection limits = 0.246ng/mL
for IgG, 0.178ng/mL for F(ab
 )2, and 0.162ng/mL for Fab),
but the increments were relatively small. This may result
from a change of the performance-controlling factor when
the antibody density increased, which will be cleared in the
rest of this paper.
Although the site-directly biotinylated fragments gave
the best performances regardless of the surface density, a
high density of the random IgG immobilization signiﬁcantly
enhanced the sensitivity. The fragmented products may
have been immobilized in a controlled orientation as well
as having ﬂexible steric freedom and, consequently, had
better accessibility to the antigen. This will be discussed
in more detail below. As the surface density increases in
the random preparation, the antibodies may change their
molecular conformation into a more accessible orientation
via self-assembly [2]. However, the use of a large quantity
of antibodies as the capture may cause unwanted problems,
for example, an increase in non-speciﬁc binding of the
enzyme-labeled detection antibody to the immobilized layer
[18] or negatively inﬂuencing the system [2, 3]. The site-
directly prepared fragments immobilized at a 10 times lower
densitythantherandomIgGgaveapproximatelyanidentical
sensitivity. In this context, fragments with such performance
would be preferable in most immunoassays that require a
high signal-to-noise ratio as a precondition for enhanced
detection capability.
3.3. Analyses of the Capture Antibody Performance. The com-
plex formation of antigen with the immobilized antibody is
aﬀected mainly by three factors: method of immobilization,
surface density of the antibody, and size of antigen [2].
In general, these alter not only the density of reactive
binding sites on the surfaces, but also the binding aﬃnity
of the antigen to the immobilized antibody. The number of
reactive binding sites represents the status of the molecular
orientation of the layer, and the aﬃnity represents the steric
freedom of the antibody accessible to the antigen. Therefore,
these two parameters were used to analyze the improved
performances of the site-directly biotinylated and suitably
fragmented antibodies.
3.3.1. Surface Density of Reactive Binding Sites. To determine
the reactive binding sites of the immobilized antibody,
Scatchard analysis [13] can be carried out with a sandwich-
type enzyme immunoassay using a microtiter plate for
relatively easy measurements. The use of the detection
antibody labeled with an enzyme (e.g., HRP), however, may
sterically hinder binding between the antigen (e.g., cTnI)
and the capture antibody. We performed these experiments
and analysis based on the following four assumptions: (1)
The binding sites on the surfaces are uniform for reaction
with antigen; (2) Each antigen-antibody binding event is
independent of one another; (3) Dissociation of the complex
during incubation and washing is negligible; and (4) The
detection antibody labeled with the enzyme covers all of
the binding complexes such that one enzyme molecule
represents a paired complex.
While the ﬁrst three assumptions are usually applicable
to any solid phase immuoassay, the fourth may be dependent
on the quality of labeled detection antibody. The detection
antibody used in this study was chemically coupled to HRP,
which was analyzed by SDS-PAGE. From this analysis we
found that the major portion (over 80%) of protein was
indeed positioned at the 200kDa band (data not shown).Journal of Biomedicine and Biotechnology 7
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Figure 4: Comparison of the reactive antibody densities immo-
bilized on the solid surfaces via biotin-streptavidin linkage. At a
constant concentration of antibody, the reactive antibody density
was determined by means of Scatchard analysis. The same pro-
cedure was repeated with diﬀerent antibody preparations of IgG,
F(ab
 )2, and Fab. Standard deviations of triplicate repetition for
each measurement were shown.
Since the molecular weights of the antibody and HRP
are 155 and 44kDa, respectively, the conjugation ratio
on average should be very close to one. In addition, the
three diﬀerent types of antibodies, that is, whole IgG,
F(ab
 )2, and Fab, employed in this study had approximately
same association/dissociation rate constants when measured
using a surface plasmon resonance sensor system under the
identicalconditions.Thisindicatedthatthefragmentationof
the antibody using protease did not alter the binding kinetic
properties.
Under these assumptions, the surface density of the
binding sites participating in the antigen-antibody reac-
tion was determined by means of the Scatchard analysis
for four diﬀerent preparations of antibody: randomly or
site-directly biotinylated whole IgG, site-directly prepared
F(ab
 )2, and site-directly synthesized Fab. The quantity of
complex formation was estimated on the basis of the HRP
activity coupled to the detection antibody, and the bound
over the unbound antigen was plotted against the bound
antigen concentration. Identical experiments were repeated
at diﬀerent antigen concentrations. For a Scatchard plot, a
regression line was prepared to minimize errors between
the values measured and estimated. The surface density of
the binding sites and aﬃnity was determined from the x-
interceptandslope,respectively,oftheScatchardplot[13].It
is worth noting that the Scatchard plot was linear, indicating
that the four assumptions proposed above were valid.
The density of binding sites available for the complex
formation was determined at a constant concentration
of each antibody, which was then replicated at diﬀerent
concentrations (Figure 4). At a low antibody concentration
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Figure 5: Comparison of binding aﬃnities for the four diﬀerent
antibody preparations, as described in Figure 3, when plotted
against the concentration added. The aﬃnity was measured simul-
taneously with the surface density by means of Scatchard analysis.
Each measurement were repeated three times and the resulting
deviations were marked.
(e.g., 0.5pmol/mL), the randomly biotinylated IgG showed
a signiﬁcantly low reactivity comparing to the site-directly
prepared antibody products, although the total number
of immobilized antibody was higher (data not shown).
However, this gap decreased as the antibody concentration
increased,whichindicatesthattherewasagradualformation
of a self-assembled molecular layer on the surfaces [2]. For
the site-directed preparations, their relative densities were in
an order of Fab > F(ab
 )2 >I g Gat a low concentration,
andbecameapproximatelythesamebutstillgreaterthanIgG
as the concentration increased. These results indicate that
the fragmented preparations essentially oriented the binding
sites to face the bulk solution, but it may be very diﬃcult
for IgG to bind to the solid surfaces without impairing the
bindingsitesforthereaction.There,however,couldbesubtle
discrepancies between the fragmented species with regard to
accessibility to the antigen present in solution, which will be
further analyzed in terms of the binding aﬃnity below.
3.3.2. Binding Aﬃnity. As described above, the binding
aﬃnity of the immobilized antibody can also be determined
concurrently with the reactive density of antibody binding
sites from the Scatchard analysis. The binding aﬃnities of
four diﬀerent types of the biotinylated antibody species were
plotted against the antibody concentration added (Figure 5).
Compared with the randomly immobilized IgG, the site-
directly prepared antibodies (IgG, F(ab
 )2, and Fab) showed
high aﬃnities over the entire antibody concentration range
tested. Among the site-directed preparations, the relative
aﬃnities were consistent (Fab > F(ab
 )2 >I g G )r e g a r d l e s s8 Journal of Biomedicine and Biotechnology
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Figure 6: Equilibrium binding models of immobilized antibodies
at solid surfaces. The models were devised on the basis of the
variationpatternsofthereactiveantibodydensity(refertoFigure 4)
and binding aﬃnity (refer to Figure 5) against the antibody
concentration for four diﬀerent biotinylated preparations (see text
for details). The major factor controlling the antigen-antibody
complex formation seemed to be molecular orientation at a low
antibody density (left) and accessibility at a high density (right).
oftheconcentration,suggestingformationofuniqueconfor-
mations to each antibody species upon insolubilization onto
the matrix.
3.4. Determination of Performance-Controlling Factors. Con-
formations of each antibody preparation at the solid surfaces
could be distinctive and determined mainly according to
diﬀerences in the molecular shape (shown as IgG, F(ab
 )2,
and Fab) and biotinylation method (Figure 6). Among the
antibodies tested, both of the native IgG type biotinylated
using either the random Figure (6(a)) or site-directed
method Figure (6(b)) showed the lowest binding aﬃnities
(refer to Figure 5), which may be linked to the presence
of Fc. Although the Fc region has deﬁnite biological
roles in vivo [19], this can hinder the attainment of a
molecular orientation suitable for antigen-antibody binding
when immobilized under an artiﬁcial environment. The IgG
preparation did indeed seem to be present on the solid
surface layer in a conﬁguration, that is, “side-on”, with
multiple contacts, which brought the binding sites of the
moleculesintotheproximityofthesurface.Thus,thesurface
can partially restrain the steric freedom of immobilized
molecules required for antigen-antibody binding, resulting
in a reduction of the binding aﬃnity (known as surface
eﬀect) [2]. Between the biotinylation methods, the random
protocol resulted in the worse conﬁguration (e.g., “top-on”)
and was the major factor that reduced the number of reactive
binding sites, particularly, when the surface density was low
(refer to Figure 4).
The other two site-directly synthesized fragments with-
out Fc, F(ab
 )2 and Fab, which relieved the surface eﬀect
whenusedasthecaptureantibody(refertoFigure 5),arealso
diﬀerentintheirshapewithrespecttothenumberofbinding
units. The F(ab
 )2 were immobilized via the hinge and sat on
the surfaces in an orientation that turned the binding sites
toward the bulk solution (Figure 6(c)). Since the molecules
consisted of two binding sites located on the opposite ends
of the left and right arms, the antigens in solution had to
diﬀuse in a lateral direction to approach the sites to form
the binding complex. In contrast, since the Fab fragment
consisted of a single binding unit, it could be immobilized
in an erect position where the binding site faced the bulk
solution even though the Fab fragment was biotinylated on
the same region (Figure 6(d)). In this case, the antigens can
access the binding sites in the vertical direction, which may
be more free of diﬀusion limitations caused by the surface
layers present on the solid matrix.
The analyses done in this study show that factors
controlling the performance of the capture antibody seem
to be diﬀerent according to the antibody density present
on the solid surfaces. When the antibody density was
low, orientational arrangement of the molecules mainly
limited the number of binding sites for antigen in solution.
Particularly, in case of randomly biotinylated IgG, the
antibody may be immobilized mostly in “top-on” and “side-
on” conﬁgurations, resulting in an inaccessible binding site.
The site-directly prepared IgG may also have a “side-on”
conformation due to the presence of the Fc region, which
could decrease the accessibility of the antigen in solution.
When the density increased, a molecular layer organization
called self-assembly occurred and under such crowding
conditions accessibility of the antigen to the binding sites
could alter the binding aﬃnity. In the case of antibody
moleculeswithtwoassociatedbindingunits,theantigenscan
only laterally access the immobilized sites by diﬀusion. This
process could be regulated by the molecular layer formed on
thesurfaces,whichwasmorepronouncedprovidedthesteric
freedom of the antibody was restricted by, for instances,
the presence of Fc and immobilization via multiple biotin-
streptavidin linkages.
4. Conclusions
Various antibody fragments, F(ab
 )2 and Fab, biotinylated at
thehingeregionwereproducedandwhenusedasthecapture
antibody in a sandwich immunoassay for cTnI displayed
an enhanced analytical sensitivity that was about 6 times
higher than the randomly biotinylated whole IgG under a
low antibody density condition. This performance was com-
parable to that of the randomly prepared IgG immobilized
at a 10 times higher density on the solid surfaces. Such a
high detection capability with the scanty fragments could
result mainly from a controlled conformation of the captureJournal of Biomedicine and Biotechnology 9
antibody and also from the ﬂexibility due to the absence of
Fc, which oﬀer conditions suitable for the binding complex
formation. These features would be beneﬁcial in immuno-
analytical systems for the reduction of non-speciﬁc binding
caused by protein-to-protein interactions or even by cross-
reaction between antibody species employed as reagents.
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